Paydirt
MR
Insider

Mark Ragosa

CHIEF FINANCIAL OFFICER · Kiniksa Pharmaceuticals International

Mark Ragosa (CHIEF FINANCIAL OFFICER) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $3.4M of KNSA (36,563 sh across 3 lots, as filed), executed Nov 2. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.1M
shares × price, as filed
Last traded
Nov 2
Filed Nov 3

Median ADV $60.8M across their filed names

Open performance→
Volume by month
$3.4M$1.7M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $893KMar 2025 · sells $1.6MMay 2025 · sells $2.3MJun 2025 · sells $527KAug 2025 · sells $621KNov 2025 · sells $815KDec 2025 · sells $1.8MJan 2026 · sells $503KFeb 2026 · sells $772KMar 2026 · sells $1.7MNov 2026 · sells $3.4M
Buys $0 Sells $15.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 6 filings

Sector per market data · by filing · past 12 months

Most traded names
KNSA Kiniksa Pharmaceuticals International, plc KNSA · 0 buys · 14 sells 14 filings
Recent filings
KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $3.4M
36,563 sh across 3 lots
Exec Nov 2
Filed Nov 3 · 6:32 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $1.7M
36,722 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $772K
17,845 sh across 2 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $503K
12,000 sh × $41.89
Exec Jan 8
Filed Jan 9 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $1.8M
42,841 sh × $41.49
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $815K
19,900 sh × $40.94
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $621K
18,889 sh × $32.89
Exec Aug 4 2025
Filed Aug 6 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $527K
18,299 sh × $28.80
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET More filings →